Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis—effects of pancreatic enzyme supplementation
P Kuo, JE Stevens, A Russo, A Maddox… - The Journal of …, 2011 - academic.oup.com
P Kuo, JE Stevens, A Russo, A Maddox, JM Wishart, KL Jones, H Greville, D Hetzel…
The Journal of Clinical Endocrinology & Metabolism, 2011•academic.oup.comContext: Postprandial hyperglycemia is an important clinical problem in cystic fibrosis (CF),
but the contribution of fat malabsorption, rapid gastric emptying, and the incretin axis has not
been widely considered. Objective: The aim of this study was to evaluate these aspects of
gut function in nondiabetic CF patients. Design and Setting: We conducted a randomized,
double-blind, placebo-controlled crossover study at a clinical research laboratory. Patients:
Five nondiabetic CF patients (three males; age, 25.8±1.0 yr; body mass index, 20.2±1.1 …
but the contribution of fat malabsorption, rapid gastric emptying, and the incretin axis has not
been widely considered. Objective: The aim of this study was to evaluate these aspects of
gut function in nondiabetic CF patients. Design and Setting: We conducted a randomized,
double-blind, placebo-controlled crossover study at a clinical research laboratory. Patients:
Five nondiabetic CF patients (three males; age, 25.8±1.0 yr; body mass index, 20.2±1.1 …
Context
Postprandial hyperglycemia is an important clinical problem in cystic fibrosis (CF), but the contribution of fat malabsorption, rapid gastric emptying, and the incretin axis has not been widely considered.
Objective
The aim of this study was to evaluate these aspects of gut function in nondiabetic CF patients.
Design and Setting
We conducted a randomized, double-blind, placebo-controlled crossover study at a clinical research laboratory.
Patients
Five nondiabetic CF patients (three males; age, 25.8 ± 1.0 yr; body mass index, 20.2 ± 1.1 kg/m2) with exocrine pancreatic insufficiency and six healthy subjects of similar age and body mass index participated in the study.
Interventions
CF patients consumed a radiolabeled mashed potato meal on 2 separate days, together with four capsules of Creon Forte (100,000 IU lipase) or placebo. Healthy subjects consumed the meal once, without pancreatic enzymes.
Main Outcome Measures
Gastric emptying was measured using scintigraphy, and blood was sampled frequently for blood glucose and plasma glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon concentrations.
Results
CF patients had more rapid gastric emptying (P < 0.001), impaired secretion of GLP-1 (P < 0.01) and GIP (P < 0.001), and greater postprandial glycemic excursions (P < 0.001) than healthy subjects. Pancreatic enzyme supplementation normalized gastric emptying and GLP-1 secretion and tended to increase glucagon (P = 0.08), but did not completely restore GIP secretion or normalize postprandial blood glucose. There was an excellent correlation between gastric emptying and blood glucose concentration at 60 min (R = 0.75; P = 0.01).
Conclusions
Pancreatic enzyme supplementation plays an important role in incretin secretion, gastric emptying, and postprandial hyperglycemia in CF.
Oxford University Press